NewAmsterdam Pharma Company N.V. earnings per share and revenue

NAMS earnings per share for the last quarter are -1.06 USD whereas the estimation was -0.62 USD which accounts for -71.54% surprise. Företagets omsättning för samma period uppgår till 1.40 M USD trots den uppskattade siffran 1.62 M USD. Estimated earnings per share for the next quarter are -0.58 USD, and revenue is expected to reach 1.20 M USD. Also watch annual changes over time to get a bigger picture of NAMS earnings per share and revenue dynamics.